Peptide chemistry toolbox–Transforming natural peptides into peptide therapeutics

M Erak, K Bellmann-Sickert, S Els-Heindl… - Bioorganic & medicinal …, 2018 - Elsevier
The development of solid phase peptide synthesis has released tremendous opportunities
for using synthetic peptides in medicinal applications. In the last decades, peptide …

Current strategies in extending half-lives of therapeutic proteins

R Zaman, RA Islam, N Ibnat, I Othman, A Zaini… - Journal of controlled …, 2019 - Elsevier
Macromolecular protein and peptide therapeutics have been proven to be effective in
treating critical human diseases precisely. Thanks to biotechnological advancement, a huge …

[HTML][HTML] pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics

L Palanikumar, S Al-Hosani, M Kalmouni… - Communications …, 2020 - nature.com
The practical application of nanoparticles (NPs) as chemotherapeutic drug delivery systems
is often hampered by issues such as poor circulation stability and targeting inefficiency …

[HTML][HTML] Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics

Y Ding, JP Ting, J Liu, S Al-Azzam, P Pandya, S Afshar - Amino Acids, 2020 - Springer
With the development of modern chemistry and biology, non-proteinogenic amino acids
(NPAAs) have become a powerful tool for developing peptide-based drug candidates. Drug …

[HTML][HTML] Cell membrane-derived vesicles for delivery of therapeutic agents

QV Le, J Lee, H Lee, G Shim, YK Oh - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Cell membranes have recently emerged as a new source of materials for molecular delivery
systems. Cell membranes have been extruded or sonicated to make nanoscale vesicles …

[HTML][HTML] Principles and current clinical landscape of multispecific antibodies against cancer

M Elshiaty, H Schindler, P Christopoulos - International journal of …, 2021 - mdpi.com
Building upon the resounding therapeutic success of monoclonal antibodies, and supported
by accelerating progress in engineering methods, the field of multispecific therapeutic …

Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics

A Zorzi, S Linciano, A Angelini - MedChemComm, 2019 - pubs.rsc.org
Peptides and small protein scaffolds are gaining increasing interest as therapeutics.
Similarly to full-length antibodies, they can bind a target with a high binding affinity and …

[HTML][HTML] Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates

MDT Torres, CN Pedron, Y Higashikuni… - Communications …, 2018 - nature.com
Antimicrobial peptides (AMPs) constitute promising alternatives to classical antibiotics for the
treatment of drug-resistant infections, which are a rapidly emerging global health challenge …

Chemical stability of metal‐organic frameworks for applications in drug delivery

H Bunzen - ChemNanoMat, 2021 - Wiley Online Library
Structural variety, tunable porosity and opportunities for functionalization make metal‐
organic frameworks (MOFs) promising materials for applications in medicine as drug …

Chemical strategies for half-life extension of biopharmaceuticals: lipidation and its alternatives

EM Bech, SL Pedersen, KJ Jensen - ACS Medicinal Chemistry …, 2018 - ACS Publications
Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its
Alternatives | ACS Medicinal Chemistry Letters ACS ACS Publications C&EN CAS Find my …